February 13, 2025 - 03:11

The Senate has officially voted to advance the nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services. This significant step paves the way for a final vote on his confirmation, which is anticipated to take place in the coming days. Kennedy, a prominent figure known for his advocacy in public health and environmental issues, has garnered both support and opposition throughout the nomination process.
His candidacy has sparked discussions across various sectors, with supporters highlighting his commitment to improving health policies and addressing public health challenges. Critics, however, have raised concerns regarding his controversial views on vaccines and public health strategies. As the Senate prepares for the final vote, all eyes will be on the outcome, which could have lasting implications for health policy in the United States. The decision will reflect the Senate's stance on Kennedy's qualifications and vision for the Department of Health and Human Services.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...